283 related articles for article (PubMed ID: 33190955)
1. Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments.
Juárez-López D; Schcolnik-Cabrera A
Arch Med Res; 2021 Apr; 52(3):243-251. PubMed ID: 33190955
[TBL] [Abstract][Full Text] [Related]
2. Perspectives on Drug Repurposing.
Schcolnik-Cabrera A; Juárez-López D; Duenas-Gonzalez A
Curr Med Chem; 2021; 28(11):2085-2099. PubMed ID: 32867630
[TBL] [Abstract][Full Text] [Related]
3. Repurposing old molecules for new indications: Defining pillars of success from lessons in the past.
Mittal N; Mittal R
Eur J Pharmacol; 2021 Dec; 912():174569. PubMed ID: 34653378
[TBL] [Abstract][Full Text] [Related]
4. Drug repurposing from the perspective of pharmaceutical companies.
Cha Y; Erez T; Reynolds IJ; Kumar D; Ross J; Koytiger G; Kusko R; Zeskind B; Risso S; Kagan E; Papapetropoulos S; Grossman I; Laifenfeld D
Br J Pharmacol; 2018 Jan; 175(2):168-180. PubMed ID: 28369768
[TBL] [Abstract][Full Text] [Related]
5. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
6. Drug repurposing in rare diseases: Myths and reality.
Fetro C; Scherman D
Therapie; 2020 Apr; 75(2):157-160. PubMed ID: 32241561
[TBL] [Abstract][Full Text] [Related]
7. Old wine in new bottles: Drug repurposing in oncology.
Antoszczak M; Markowska A; Markowska J; Huczyński A
Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
[TBL] [Abstract][Full Text] [Related]
8. Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies.
Jain P; Jain SK; Jain M
Curr Mol Med; 2021; 21(2):111-132. PubMed ID: 32560606
[TBL] [Abstract][Full Text] [Related]
9. High Throughput and Computational Repurposing for Neglected Diseases.
Hernandez HW; Soeung M; Zorn KM; Ashoura N; Mottin M; Andrade CH; Caffrey CR; de Siqueira-Neto JL; Ekins S
Pharm Res; 2018 Dec; 36(2):27. PubMed ID: 30560386
[TBL] [Abstract][Full Text] [Related]
10. Regulatory considerations and intellectual property rights of repurposed drugs.
Afzaal H; Waseem T; Saeed A; Noori FA; Obaidullah ; Babar MM
Prog Mol Biol Transl Sci; 2024; 205():357-375. PubMed ID: 38789186
[TBL] [Abstract][Full Text] [Related]
11. Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery.
Chen H; Wu J; Gao Y; Chen H; Zhou J
Curr Top Med Chem; 2016; 16(19):2107-14. PubMed ID: 26881709
[TBL] [Abstract][Full Text] [Related]
12. Sources and Targets for Drug Repurposing: Landscaping Transitions in Therapeutic Space.
Mucke HA; Mucke E
Assay Drug Dev Technol; 2015; 13(6):319-24. PubMed ID: 26241211
[TBL] [Abstract][Full Text] [Related]
13. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
14. Drug repurposing: progress, challenges and recommendations.
Pushpakom S; Iorio F; Eyers PA; Escott KJ; Hopper S; Wells A; Doig A; Guilliams T; Latimer J; McNamee C; Norris A; Sanseau P; Cavalla D; Pirmohamed M
Nat Rev Drug Discov; 2019 Jan; 18(1):41-58. PubMed ID: 30310233
[TBL] [Abstract][Full Text] [Related]
15. Drug Repurposing for Rare Diseases.
Roessler HI; Knoers NVAM; van Haelst MM; van Haaften G
Trends Pharmacol Sci; 2021 Apr; 42(4):255-267. PubMed ID: 33563480
[TBL] [Abstract][Full Text] [Related]
16. Drug repurposing: a systematic review on root causes, barriers and facilitators.
Krishnamurthy N; Grimshaw AA; Axson SA; Choe SH; Miller JE
BMC Health Serv Res; 2022 Jul; 22(1):970. PubMed ID: 35906687
[TBL] [Abstract][Full Text] [Related]
17. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
18. Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data.
Pulley JM; Rhoads JP; Jerome RN; Challa AP; Erreger KB; Joly MM; Lavieri RR; Perry KE; Zaleski NM; Shirey-Rice JK; Aronoff DM
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():333-352. PubMed ID: 31337270
[TBL] [Abstract][Full Text] [Related]
19. Creating New Economic Incentives for Repurposing Generic Drugs for Unsolved Diseases Using Social Finance.
Bloom BE
Assay Drug Dev Technol; 2015 Dec; 13(10):606-11. PubMed ID: 26284286
[TBL] [Abstract][Full Text] [Related]
20. Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria.
Peyclit L; Baron SA; Rolain JM
Front Cell Infect Microbiol; 2019; 9():193. PubMed ID: 31245302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
